Sinovac Biotech gets Chinese license to make flu vaccine

Sinovac Biotech said that China's State Food and Drug Administration (SFDA) issued a production license for Sinovac's proprietary influenza flu vaccine, Anflu. Though the company already had won a new drug certificate from the Chinese government for the vaccine, it required a separate license to start production. The company has established its flu production line, which has a capacity of 2 million doses per year. Sales are expected to begin in the last quarter of 2005.

- read this press release for more

PLUS: SinoFresh achieves in vitro success with antiviral nasal spray. Release